Status:
UNKNOWN
Determination of Sarcopenia Risk and Related Factors in Pediatric Oncological Patients
Lead Sponsor:
Trakya University
Conditions:
Sarcopenia
Pediatric Cancer
Eligibility:
All Genders
2-18 years
Brief Summary
In children, both malnutrition and sarcopenia are associated with prolongation of hospital stay, increased morbidity, mortality, and health-related complications. While the decrease in muscle strength...
Detailed Description
As incidence and survival, rates increase in childhood and adolescent cancers, the importance of rehabilitation in this area increases (1-5). Functional limitations in the physical and cognitive domai...
Eligibility Criteria
Inclusion
- Be between the ages of 2-18 years
- Being under pediatric oncology outpatient/clinical follow-up
- Being able to stand unaided without using a cane/walker
Exclusion
- Having any of the diagnoses of hypertension, any cardiac arrhythmia-conduction disorders, coronary artery disease, heart failure, diabetes mellitus, hyperlipidemia, cardiovascular diseases, COPD, pulmonary infection, active infection.
- Depression Illness that causes balance problems
- Peripheral vascular disease
- Presence of disease that prevents standing up with support.
- Presence of diseases that may cause muscle mass loss (cerebral palsy, neuromuscular disease, congenital metabolic disorder, brain damage) mental retardation
- Children with a severe emotional disorder, adjustment disorder
- Physical disability to prevent safe and appropriate testing
- Having used anti-flu medicine in the last 1 week
- Failure to obtain consent.
Key Trial Info
Start Date :
October 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 15 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05294380
Start Date
October 4 2021
End Date
September 15 2022
Last Update
March 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Trakya University Medical Faculty
Edirne, Turkey (Türkiye), 22030